Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17429623rdf:typepubmed:Citationlld:pubmed
pubmed-article:17429623lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17429623lifeskim:mentionsumls-concept:C0280100lld:lifeskim
pubmed-article:17429623lifeskim:mentionsumls-concept:C0123931lld:lifeskim
pubmed-article:17429623lifeskim:mentionsumls-concept:C0205390lld:lifeskim
pubmed-article:17429623lifeskim:mentionsumls-concept:C0201734lld:lifeskim
pubmed-article:17429623lifeskim:mentionsumls-concept:C0205195lld:lifeskim
pubmed-article:17429623lifeskim:mentionsumls-concept:C0950721lld:lifeskim
pubmed-article:17429623pubmed:issue3lld:pubmed
pubmed-article:17429623pubmed:dateCreated2007-12-17lld:pubmed
pubmed-article:17429623pubmed:abstractText7-Hydroxystaurosporine (UCN-01) is a protein kinase inhibitor that inhibits several serine-threonine kinases including PKC and PDK1. Due to the preclinical synergistic effects seen with topoisomerase I inhibitors and non-overlapping toxicity, UCN-01 and irinotecan were combined in a dose-finding study designed to determine the maximum tolerated dose (MTD), toxicity profile, and pharmacokinetics (PK) of UCN-01 and irinotecan.lld:pubmed
pubmed-article:17429623pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:languageenglld:pubmed
pubmed-article:17429623pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:citationSubsetIMlld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17429623pubmed:statusMEDLINElld:pubmed
pubmed-article:17429623pubmed:monthMarlld:pubmed
pubmed-article:17429623pubmed:issn0344-5704lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:DonehowerRoss...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:BakerSharyn...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:HidalgoManuel...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:RudekMichelle...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:DanceyJanetJlld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:CarducciMicha...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:JimenoAntonio...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:LaheruDaniel...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:MessersmithWe...lld:pubmed
pubmed-article:17429623pubmed:authorpubmed-author:PurcellThomas...lld:pubmed
pubmed-article:17429623pubmed:issnTypePrintlld:pubmed
pubmed-article:17429623pubmed:volume61lld:pubmed
pubmed-article:17429623pubmed:ownerNLMlld:pubmed
pubmed-article:17429623pubmed:authorsCompleteYlld:pubmed
pubmed-article:17429623pubmed:pagination423-33lld:pubmed
pubmed-article:17429623pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:meshHeadingpubmed-meshheading:17429623...lld:pubmed
pubmed-article:17429623pubmed:year2008lld:pubmed
pubmed-article:17429623pubmed:articleTitlePhase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.lld:pubmed
pubmed-article:17429623pubmed:affiliationThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Cancer Research Building I, Baltimore, MD, USA.lld:pubmed
pubmed-article:17429623pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17429623pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:17429623pubmed:publicationTypeClinical Trial, Phase Illd:pubmed
pubmed-article:17429623pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17429623lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17429623lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17429623lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17429623lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17429623lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17429623lld:pubmed